PHAGOMED
PhagoMed is a developer of a biotech platform designed to develop drugs and therapies.The company's platform is focused on the development of human therapeutic applications of phages and phage-derived proteins associated with urinary tract infections and bacterial vaginosis, enabling patients to get antibiotics.
PHAGOMED
Industry:
Biopharma Biotechnology
Founded:
2017-11-23
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.phagomed.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.5 M EUR
Technology used in webpage:
SPF Microsoft Azure DNS Zendesk Proofpoint One.com DNS
Similar Organizations
MedXCell
MedXCell develops and manufactures innovative off-the-shelf cellular therapies.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
Current Employees Featured
Founder
Newest Events participated
Official Site Inspections
http://www.phagomed.com
- Host name: webforward.webpod12-cph3.one.com
- IP address: 46.30.213.63
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "PhagoMed"
PhagoMed - Crunchbase Company Profile & Funding
PhagoMed is a developer of a biotech platform designed to develop drugs and therapies.The company's platform is focused on the development of human therapeutic applications of …See details»
PhagoMed Biopharma GmbH - Wien, Austria - bionity.com
Jul 1, 2019 PhagoMed Biopharma GmbH is a biotech company focused on the development of human therapeutic applications of phage therapy. Its development programs are based on the …See details»
PhagoMed - Products, Competitors, Financials, Employees, …
PhagoMed is a biotech company based in Vienna, Austria focused on developing alternatives to antibiotics. On November 10th, 2021, PhagoMed was acquired by BioNTech. Use the CB …See details»
BioNTech acquires bacteriophage company PhagoMed
Nov 17, 2021 BioNTech has announced it has completed the acquisition of the bacteriophage therapy, Austrian company PhagoMed GmbH to “increase its infectious disease portfolio …See details»
PhagoMed Biopharma 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for PhagoMed Biopharma. Use the PitchBook Platform to explore the full profile.See details»
PhagoMed - Company Profile - Tracxn
Aug 31, 2024 PhagoMed - Company developing alternatives to antibiotics through their expertise in phage therapy. Acquired by BioNTech. Raised a total funding of $1.7M over 2 …See details»
Endless Frontier Labs
PhagoMed develops precision therapies for chronic bacterial infections. Its lead program, PM-477, targets Recurrent Bacterial Vaginosis (rBV), a chronic vaginal disease that affects 100 million …See details»
Overview, News & Similar companies - ZoomInfo.com
View PhagoMed Biopharma (www.phagomed.com) location in Vienna, Austria , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
BioNTech acquires PhagoMed - 2021-11-09 - Crunchbase
Nov 9, 2021 BioNTech acquires PhagoMed on 2021-11-09 for an undisclosed amountSee details»
EIT Health-supported PhagoMed acquired by BioNTech
Nov 10, 2021 BioNTech acquired PhagoMed, a start-up supported by EIT Health. PhagoMed is developing novel synthetic lysin technology for precision antimicrobial treatments and was …See details»
PhagoMed Biopharma - VentureRadar
Mar 22, 2019 "PhagoMed is at the forefront of the renaissance of phage therapy. The antibiotics crisis is accelerating along three dimensions: the death toll from multi-drug resistant infections …See details»
News | Vienna BioCenter
Dec 3, 2021 In October 2021, BioNTech expanded its infectious disease portfolio capabilities by acquiring PhagoMed Biopharma GmbH, an Austrian biotechnology company, specialized in …See details»
PhagoMed Biopharma | VentureRadar
PhagoMed is at the forefront of the renaissance of phage therapy. The antibiotics crisis is accelerating along three dimensions: the death toll from multi-drug resistant infections is rising; …See details»
PhagoMed GmbH - ACI: Advise Connect Inspire
At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To pioneer the next generation of patient-specific …See details»
PhagoMed - Funding, Financials, Valuation & Investors
PhagoMed is a developer of a biotech platform designed to develop drugs and therapies.See details»
PhagoMed Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for PhagoMed. See PhagoMed company profile and funding data.See details»
PhagoMed - Raised $1.7M Funding from 2 investors - Tracxn
Mar 25, 2025 PhagoMed has raised a total funding of $1.7M over 2 rounds from 2 investors. Investors include HEMEX and EIT Health. Their latest funding round was of $1.7M on Jul 01, …See details»
PhagoMed and phage-based pharmaceuticals - Medium
Aug 23, 2019 Alexander Belcredi: PhagoMed develops phage-based* pharmaceuticals to treat chronic infections where antibiotics fail. AB: Our co-founder Prof. Wippermann has been …See details»
Phagomed Biopharma - Extreme Tech Challenge
May 6, 2021 Novel anti-bacterials are urgently needed. Humanity faces a monumental crisis due to increasing antibiotic resistance. As a solution, PhagoMed has created a synthetic biology …See details»
Phagomed - ACI: Advise Connect Inspire
Gold Track worked with Phagomed on sharpened their storytelling through streamlining of their product offerings, data, clinical utility, Phase 1, 2 and 3 clinical strategies, as well as mapping …See details»